Last Updated:
Shares of Inventurus Knowledge Solutions noted with a costs of almost 43 percent versus the problem cost of Rs 1,329 on Thursday.
Inventurus Knowledge Solutions Share Price: Opened at Rs 1,856, noting a 39.65% rally from the problem cost, and later on rose 46.13% to Rs 1,942.10.
Shares of Inventurus Knowledge Solutions Ltd, a carrier of health care assistance solutions, made a remarkable launching on Thursday, noting with a 43% costs over the problem cost of Rs 1,329.
Inventurus Knowledge Solutions Share Price Today
Stock Performance on Listing Day
- BSE Listing: Opened at Rs 1,856, noting a 39.65% rally from the problem cost, and later on rose 46.13% to Rs 1,942.10.
- NSE Listing: Debuted at Rs 1,900, showing a 42.96% dive.
- Market Valuation: The firm’s market cap got to Rs 32,282.35 crore.
IPO Details and Strong Subscription
- Issue Size: Rs 2,498 crore.
- Price Band: Rs 1,265-1,329 per share.
- Subscription: The IPO got 52.68 times registration on its closing day.
- Offer For Sale (OFS): The IPO was completely an OFS of 1.88 crore equity shares by marketers and private investors, without fresh problem element.
- Proceeds: As the problem was completely an OFS, the firm will certainly not get any kind of profits, and the whole quantity will certainly most likely to the offering investors.
Objectives Behind the IPO
Inventurus Knowledge Solutions specified in its IPO papers that the key purposes of the share sale were:
- Gaining benefits of noting equity shares on stock market.
- Enhancing exposure and brand name photo.
- Providing liquidity to existing investors.
- Establishing a public market for its equity shares.
About Inventurus Knowledge Solutions
Inventurus Knowledge Solutions Ltd is a technology-enabled health care remedies company concentrated on treatment enablement. The firm aids doctor ventures mostly in the United States, Canada, and Australia, with a solid focus on the United States market.
Client Base: Serves over 800 health care organisations, consisting of wellness systems, scholastic clinical centres, multi-specialty and single-specialty clinical teams, along with supplementary health care organisations.
Backers: The firm is sustained by Rekha Jhunjhunwala and RARE Enterprises.
The solid market launching emphasizes capitalist self-confidence in the firm’s healthcare-centric remedies and its development possibility in worldwide markets.
&w=100&resize=100,70&ssl=1 "Apple deserts prepare for hardware-as-a-subscription design for apples iphone")